Harrow Health logo

Harrow HealthNASDAQ: HROW

Profile

Sector:

Healthcare

Country:

United States

IPO:

28 September 2007

Next earnings report:

13 November 2024

Last dividends:

N/A

Next dividends:

N/A
$1.65 B
-21%vs. 3y high
79%vs. sector
-vs. 3y high
-vs. sector
-92%vs. 3y high
99%vs. sector
-21%vs. 3y high
76%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:31:11 GMT
$46.53+$1.10(+2.42%)

Dividend

No data over the past 3 years
$48.94 M$52.81 M
$48.94 M-$6.47 M

Analysts recommendations

Institutional Ownership

HROW Latest News

Harrow (HROW) Upgraded to Strong Buy: What Does It Mean for the Stock?
zacks.com30 October 2024 Sentiment: POSITIVE

Harrow (HROW) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Wall Street Analysts Believe Harrow (HROW) Could Rally 25.95%: Here's is How to Trade
zacks.com29 October 2024 Sentiment: POSITIVE

The average of price targets set by Wall Street analysts indicates a potential upside of 26% in Harrow (HROW). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Recent Price Trend in Harrow (HROW) is Your Friend, Here's Why
zacks.com22 October 2024 Sentiment: POSITIVE

Harrow (HROW) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

I Am Banking On The Silver Tsunami With Big Dividends
seekingalpha.com12 October 2024 Sentiment: POSITIVE

There are sectors that experience demand irrespective of economic climate. I like cold hard cash placed in my account. We discuss big dividends from healthcare, yields +8.3%.

Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains?
zacks.com04 October 2024 Sentiment: POSITIVE

Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Harrow Inc (HROW) Shares Up 3.26% on Oct 2
gurufocus.com02 October 2024 Sentiment: POSITIVE

Shares of Harrow Inc (HROW, Financial) surged 3.26% in mid-day trading on Oct 2. The stock reached an intraday high of $46.10, before settling at $45.90, up from its previous close of $44.45.

Harrow (HROW) Reports Q2 Loss, Tops Revenue Estimates
zacks.com07 August 2024 Sentiment: POSITIVE

Harrow (HROW) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.02 per share a year ago.

Harrow (HROW) Soars 12.9%: Is Further Upside Left in the Stock?
zacks.com21 June 2024 Sentiment: POSITIVE

Harrow (HROW) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Harrow, Inc. (HROW) Q1 2024 Earnings Call Transcript
Seeking Alpha14 May 2024 Sentiment: NEGATIVE

Harrow, Inc. (NASDAQ:HROW) Q1 2024 Earnings Call Transcript on May 14, 2024 at 8:00 AM ET with Company Representatives Jamie Webb, Mark L. Baum, and Andrew Boll. Conference Call Participants include Jeffrey Cohen, Chase Knickerbocker, and Brooks O'Neil. Welcome to the Harrow, Inc. First Quarter 2024 Earnings Conference Call.

Harrow: Merits A Buy On Sales Potential
Seeking Alpha02 May 2024 Sentiment: POSITIVE

Harrow, Inc. stocks have decreased by 45% since the spring of 2023, but the introduction of Iheezo and Vevye indicates a possible recovery. Iheezo, an eye numbing agent, has a large market potential and is projected to generate substantial profits for Harrow. Vevye, a treatment for dry eyes, also has a considerable market opportunity and has shown positive results since its launch.

  • 1(current)
  • 2

What type of business is Harrow Health?

Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX and FLAREX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe and the eye; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and NATACYN, a sterile, antifungal drug for the treatment of fungal blepharitis, conjunctivitis, and keratitis. In addition, it offers TOBRADEX ST, a tobramycin and dexamethasone ophthalmic suspension; VERKAZIA cyclosporine ophthalmic emulsion; NEVANAC, a non-steroidal, anti-inflammatory eye drop; and FRESHKOTE preservative free (PF) is a lubricant eye drop. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

What sector is Harrow Health in?

Harrow Health is in the Healthcare sector

What industry is Harrow Health in?

Harrow Health is in the Drug Manufacturers - Specialty & Generic industry

What country is Harrow Health from?

Harrow Health is headquartered in United States

When did Harrow Health go public?

Harrow Health initial public offering (IPO) was on 28 September 2007

What is Harrow Health website?

https://www.harrow.com

Is Harrow Health in the S&P 500?

No, Harrow Health is not included in the S&P 500 index

Is Harrow Health in the NASDAQ 100?

No, Harrow Health is not included in the NASDAQ 100 index

Is Harrow Health in the Dow Jones?

No, Harrow Health is not included in the Dow Jones index

When was Harrow Health the previous earnings report?

No data

When does Harrow Health earnings report?

The next expected earnings date for Harrow Health is 13 November 2024